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“I haven’t evenphonedmydoctor yet.”Theadvicegiving role
of thepharmacistduringconsultations formedicationreview
withpatientsaged80ormore:qualitativediscourseanalysis
Charlotte Salter, lecturer in consultation skills,1 Richard Holland, senior lecturer in public healthmedicine,1 Ian
Harvey, professor of epidemiology and public health,1 Karen Henwood senior lecturer2
Objective To explore the advice giving role of pharmacists
during consultation for medication review with patients
aged 80 or more.
Design Discourse analysis.
Setting Participants’ homes.
Participants Subsample of consultations within a large
randomised trial of home medication review among
patients aged 80 or more who had been admitted to
hospital.
Main outcome measures Extent to which advice given by
pharmacists was accepted and acknowledged by
patients.
Results Pharmacists found many opportunities to offer
advice, information, and instruction. These advice giving
modeswere rarely initiatedby the patients andwere given
despite a no problem response and deliberate displays of
competence and knowledge by patients. Advicewas often
resisted or rejected and created interactional difficulties
and awkward moments during the consultations.
Conclusions The advice giving role of pharmacists during
consultations with patients aged 80 or more has the
potential to undermine and threaten the patients’
assumed competence, integrity, and self governance.
Caution is needed in assuming that commonsense
interventions necessarily lead to health gain.
INTRODUCTION
The UK government white paper “Choosing health”
proposes an approach to healthier lifestyles that
involves people making healthy choices through the
provision of increased access to information and low
intensity interventions and support services.1 Commu-
nity pharmacists have been seen as ideally placed to
delivermany of these preventive healthcare initiatives.
The new community pharmacy contract offers a raft of
wide ranging activities.2Medication review is one such
enhanced service. Medication review is described as a
cornerstone for themanagement of modernmedicines
and is recommended by the national service frame-
work for older people and by the National Health Ser-
vice plan.
In practice the changing role of the community phar-
macist in the United Kingdom is uncertain and under-
researched.3-6 Despite the pharmacy being the most
often visited healthcare outlet7 and viewed as ideally
placed between lay and professional networks,8 9 phar-
macists are still ultimately viewed as shopkeepers and
dispensers of medicines.10 Furthermore, the role of the
community pharmacist as advice giver or drug coun-
sellor is ill defined and diverse.11 Little training exists
for these new roles and even less in-depth research has
been done into the implications of this new philosophi-
cal approach to the work of community pharmacists
and its effect on relationships between healthcare pro-
fessionals and patients.4 12
The literature on doctor-patient communication has
a strong evidence base to suggest that good communi-
cation skills in the consultation have a significant posi-
tive effect on patient satisfaction and healthcare
outcomes such as adherence.13 14 A growing body of
knowledge also shows that these skills can be
taught.14 Research shows that patients’ reception of
advice is influenced by the conversational environ-
ment in which the advice is delivered.15 16 Premature
advice that is given without any previous questioning
of the client about the topic or without any attempt to
elicit the patient’s perspective is often not picked up or
acknowledged by the patient and is often rejected.17
We previously evaluated whether domiciliary med-
ication review affects hospital admission rates and
quality of life among people aged 80 or more.18 The
trial produced the counterintuitive finding that the
intervention was associated with increased hospital
admission and home visits by general practitioners
and did not significantly improve quality of life or
reduce the numbers of deaths. We report on a
Box 1 | Transcription conventions21
Underlining—word stressed or emphasised by speaker
Single parentheses—non-verbal, contextual, or
interpretive information
Double parentheses—unintelligible or uncertain
transcription
Units in parentheses—pauses and periods of silence, in
tenths of a second
Equals sign—no interval between adjacent utterances
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qualitative element of the trial that focuses on themed-
ication review consultation.This elementwas built into
the original trial proposal from its inception. Using in-
depth interviews and discourse analysis techniques we
explored the ways in which pharmacists and older
patients engage in the medication review consultation.
PARTICIPANTS AND METHODS
We invited patients recruited to the HOMER (home
basedmedication reviewby pharmacists) trial between
October and December 2002 to take part in the addi-
tional study. Twenty nine of 758 eligible participants
with an abbreviated mental test score of eight or more
(88.7% of the trial sample) were recruited.
Eleven of the 22 review pharmacists recruited to the
parent trial expressed an interest in taking part in the
substudy. Seven tookpart in the 29 observed and taped
consultations and four were excluded for reasons of
distance, availability, or matters concerning their
patients. Six of the pharmacists were women. The
pharmacists did not know the patients before visiting
them as they were not necessarily from the same local-
ity. They were all working as community pharmacists
and were paid on an ad hoc basis to provide the med-
ication review service. They had a minimum of
15 years’ experience (range 15-40) and at least one
postgraduate qualification each (table 1). All pharma-
cists participated in a two day training course, includ-
ing lectures on adverse drug reactions, prescribing in
elderly people (aged 80 or more), improving concor-
dance, and communication skills.
Sample selection was essentially pragmatic and
dependent on the availability of review pharmacists,
the researcher (CS), and the agreement of patients, dur-
ing the fieldwork period (97% of those approached
agreed to participate in this substudy). Participants
were representative of the parent trial (table 2). Sample
saturation was judged to have been reached when no
new styles of consultation were witnessed and when
each of the seven review pharmacists had each done a
minimum of three consultations. Patients gave
informed written consent.
One researcher (CS), a social scientist, observed,
taped, and transcribed the 29 medication review con-
sultations. She noted down any non-verbal cues, facial
expressions, and body language. Participants were
revisited by CS within a month of the original consul-
tation to collect data on their perceptions of the
encounter. In-depth interviews were carried out with
the pharmacists before and after themedication review
consultation. In addition, formal feedback meetings
with the pharmacists followed by focus group discus-
sion, enhanced validation of the analysis and findings.
Meetings once every two months with an advisory
panel ensured constant discussion of the credibility of
the research process and its findings. One to one
monthly supervision between CS and KH ensured
the analysis stage involved iterative and rigorous pro-
cedures. This three pronged approach to data collec-
tion increased the trustworthiness of the data and
subsequent analysis.19 20
ANALYSIS
CS transcribed and examined the transcriptions and
field notes by hand. The transcription conventions
adopted were those of Jefferson (box 1).21
Discourse analysis is a methodological approach
that can be used in the study of communication in
healthcare consultations.4 Activity type analysis per-
mits the identification of characteristic forms of talk
such as advice giving.22 Fine grained analysis of the
conversational properties of the consultation enabled
recognisable patterns of awkward or critical moments
to be identified. We highlighted instances where the
Table 1 | Baseline characteristics of pharmacists in primary trial and qualitative study. Values are
numbers (percentages) unless stated otherwise
Characteristics Primary trial (n=22)
Qualitative study
(n=7)
Women 13 (59) 6 (86)
Mean (SD) age (years) 41.8 (7.4) 43.4 (5.2)
Mean (SD) years since first registration 17.4 (8.2) 22.5 (5.8)
Higher qualification after registration:
Diploma, masters degree, or PhD 7 (32) 4 (57)
Postgraduate certificate only 10 (46) 2 (29)
Main employment:
Community pharmacist 12 (32) 5 (71)
Locum community work 3 (14) 2 (29)
Hospital pharmacist 5 (23) 0
Other 2 (9) 1 (14)
Previous experience:
Medication review 13 (77)* 4 (57)
Home visits† 5 (29) 2 (29)
*Data on 17 pharmacists.
†Not including delivery of drugs or supply of oxygen.
Table 2 | Baseline characteristicsof participants inprimary trial
and qualitative study. Values are numbers (percentages)
unless stated otherwise
Characteristics
Primary trial
(n=855)
Qualitative study
(n=29)
Women 534 (62.4) 18 (65)
Mean (SD) age (years) 85.5 (4.0) 83.3 (3.1)
Living alone 531 (61.1) 21 (65.5)
Mean (SD) abbreviated mental
test
8.9 (1.5) 9.2 (0.7)
Mean (SD) total No of drugs 6.3 (2.6) 6.7 (2.6)
Monitored dose system 152* (18.6) 9 (31)
Social class† 333‡ (42) 11 (37.9)
Baseline diagnosis:
Cardiovascular 278 (32.5) 10 (34.5)
Musculoskeletal 126 (14.7) 8 (27.6)
Gastrointestinal 101 (11.8) 0 (0.00)
Respiratory 97 (11.3) 4 (13.7)
Neurological 65 (7.6) 2 (6.8)
Other 188 (22.0) 5 (17.4)
*Data on 817 patients.
†I, II, or IIInm.
‡Employment details available for 793 patients.
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communicative competences of the participants were
put under pressure. The transcripts have been selected
for their representative nature and simplified for pre-
sentation and ease of reading. (Further transcripts are
available from the corresponding author4).
RESULTS
Themedication review consultations lasted an average
of 45 minutes each. The results showed a uniform
shape to the consultations. A strong mode of talking
or discourse of advice giving was identified. It was dur-
ing many of these identified episodes of advice giving
that disruptions or critical moments occurred.
The style of advice giving was essentially didactic.
The pharmacists provided advice, information, or
instruction on a constant basis throughout the consul-
tation. During the 29 taped consultations almost no
patient initiated requests for advice or information.
On only one occasion did a patient specifically
announce that he wanted to ask a question. Advice
given was often unsolicited and invariably in the
absence of a patient initiated problem or request for
advice. It was often resisted or rejected by the patients.
The patients adopted a variety of conversational stra-
tegies, including direct or indirect challenges to the
pharmacists’ authority and knowledge boundaries.
Patients’ knowledge and experience as a challenge to the
pharmacists’ advice giving role
Conversational attempts by the patients to resist advice
included assertions of knowledge and experience. The
extract in box 2 illustrates an interrogative sequence of
the type that was common during the consultations. A
key concern of the pharmacists was over use of analge-
sics. The sequence begins with the pharmacist asking if
the patient has had any changes to her medication. On
discovering that the patient has been prescribed both
paracetamol and co-codamol the pharmacist asks
whether the patient knows she cannot take both
together (line 10). The patient says “oh I don’t take
the co-codamol at themoment” (line 11), thereby effec-
tively brushing the pharmacist’s question aside. The
pharmacist, however, continues cross examining as
well as inserting advisory caveats, thus creating a famil-
iar blend of question and instruction (lines 14, 16, and
18).Despite at least four attempts by the patient to reas-
sure the pharmacist that she was not taking both drugs
and to assert her competence (lines 11, 15, 17, and 19-
21), the pharmacist still advises the patient “well the
maximum is eight in twenty four hours” (line 22). At
line 24 the pharmacist manages to impart her advice
yet again saying “you have to be careful with para-
cetamol as you already realise because co-codamol
contains paracetamol.” The patient interrupts the
pharmacist’s repeated advice giving string by saying
that, yes, she knows because she has “read all the leaf-
lets” (line 26). This kind of repetitive advice giving was
a familiar feature of the consultations.
Patients could also be categorical in their rejection of
offers of advice. In the second example (box 3) the
pharmacist asks if the patient would like to know
what his medicines are for (line 7). The patient’s
response is negative and categorical. It represents a
rebuttal that embarrasses the pharmacist and causes
interactional uncertainty (line 10).
Box 2 | Conversational attempts to resist advice
1. Ph 05. Have you had any changes since you’ve been into hospital
2. Pt 04. What medication
3. Ph 05. Hhm
4. Pt 04. No still the same things as I said to you the only thing they give
5. Pt 04. me is hhm=
6. Ph 05. =Paracetamol
7. Pt 04. Because I do take co-codamol=
8. Ph 05. =You do
9. Pt 04. Yes from the doctors
10. Ph 05. Do you know that you can’t take the two together
11. Pt 04. Oh I don’t take the co-codamol at the moment
12. Ph 05. You don’t=
13. Pt 04. =No= 14. Ph. =Do you take these (paracetamol)=
15. Pt 04. =Yes not while I’ve got those=
16. Ph 05. =So you know that its either one thing or the other=
17. Pt. 04 =Yes they did tell me at the hospital
18. Ph 05. How many would be a maximum of those
19. Pt 04. Well I was having four a day when I first went in with the pain
20. Pt 04. in fact I kept on having an injection as well but as its eased off I
21. Pt 04. take two in the morning and then two at night before I go to bed
22. Ph 05. Well the maximum is eight in twenty four hours
23. Pt. 04 Yes I know I do know yes I wouldn’t do any more than that=
24. Ph 05. =You have to be careful with paracetamol as you already realise
25. Ph 05. because co-codamol contains paracetamol and=
26. Pt 04. =Yes I have read all the leaflets because you know=
Box 3 | Categorical rejection of pharmacist’s offer of
advice
1. Ph 07. The digoxin tablets (0.3) the other tablets (0.2)
the where are
2. Ph 07. they hhm (0.4) that’s it can you tell mewhat all
of those are those
3. Ph 07.we know can you tellmewhat the other two are
for
4. Pt 01. What those for
5. Ph 07. Yeah
6. Pt 01. Not the slightest idea
7. Ph 07. Right (0.2) would you like (0.3) me to help you
out there (2.0)
8. Pt 01.Well (0.2) I I don’t want to knowwhat they’re for
so long as I’ve
9. Pt 01. got to take them that’s all that matters=
10. Ph 07. =Right okay (embarrassed laugh) (mumbles
to self checking list) (0.8)
11. Ph 07. fine okay one of the things I needed to check
as well is you you’ve been
12. Ph07. taking these tablets (0.2) hhm (0.4) howhave
you got on with them have
13. Ph 07. you had any problems with them at all
14. Pt 01. No my dear
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Advice was often given after an interruption by the
pharmacist. This meant that the patient’s perspective
was unheard and has implications for the reception and
take-up of advice. In the sequence in box 4 the pharma-
cist offers the patient a newmedicine tray. The pharma-
cist interrupts in several instances. The patient, despite
the interruption, explains how he manages (lines 2-4).
When the pharmacist makes an offer of a new tray (line
18) she receives a rebuttal, with the patient giving an
emphatic “no I ain’t that far gone yet.”
Calling on the higher authority of the doctor
One of the strongest rebuttals to the pharmacists’
attempts to counsel and give advice was patients’ use
of the higher authority of the doctor. Many examples
existed. In one consultation the pharmacist asked the
patient if hewas still taking his cod liver oil. The patient
announced that he would restart but only as “soon as
the doctor says I can.” In the sequence in box 5 the
patient consistently resists the pharmacist’s inter-
vention and line of questioning with a dismissive “I
don’t know” (lines 7, 11, and 15). The patient is a
retired nurse and of a nervous disposition because of
her physical frailty.Her sonmanages hermedicines for
her. Later in the consultation she reveals a wealth of
knowledge and experience of medicine taking. How-
ever, in common with other patients in the study she
did not want information or advice from the pharma-
cist.Her resistance in this extract culminates in her say-
ing “I haven’t even phoned my doctor yet.”
Patients’ relationships with their doctors are fore-
most in themanagement ofmedicines. The pharmacist
was often thwarted in her advice giving role by men-
tion of the doctor. In the sequence in box 6 the phar-
macist attempts to counsel the patient with advice
about her swollen ankles but is met with resistance
and a defensive tone. The patient blocks the pharma-
cist’s warning by saying that her “own doctor” will
“sort out these little problems when he comes” (lines
2-4).
In box 7 the extract takes up after a sequence of
advice giving about eye drops. The pharmacist had
told the patient that she really ought to be using her
eye drops everyday. The patient said she had not
done so for a long time and saw no reason as her eyes
seemed absolutely fine and that as they did not use eye
drops in hospital she had concluded that they could not
have been important. The pharmacist is reading
through some scripts when the patient begins with
praise for her doctors (line 7), particularly her general
practitioner. She and her husband both state vehe-
mently that they do not want to be seen as “rocking
the boat” or seem to be complaining (lines 15-18).
This provides a further illustration of howpharmacists’
intervention can have a potentially unsettling effect on
patients and their assumptions about their existing
healthcare network and medicines regimen.
DISCUSSION
Review pharmacists take every opportunity to offer
advice and information. This advice was often resisted
or rejected by the older patients in this study. Advice
was often given in the absenceof any statedproblemby
the patient and often provided even after displays of
knowledge and competence by the patient. Active
resistance was shown through displays of knowledge
and authority as well as calling on a higher authority
such as the hospital or general practitioner. Further-
more, the pharmacists’ advice giving role during the
medication review consultations seemed to have the
potential to undermine and threaten the patients’
Box 4 | Advice given after interruption by pharmacist (italics indicate overlapping
speech)
1. Ph 05. Yeah okay and you’re happy with the box that you are using
2. Pt 09. Yeah I can manage them (0.2) they ain’t all the same some of them have
3. Pt 09. got a slide but you have to watch you don’t un uncover more than one
4. Pt 09. hole=
5. Ph 05. =Yes yeah I’ve actually brought some with me here
6. Pt 09. You see
7. Ph 05. I think the one you mean is (0.2) is it like that (0.3) is it like that so you
8. Ph 05. have to be careful when you pull the slides out
9. Pt 09. That’s right yeah they’re the ones
10. Ph 05. Yeah
11. Pt 09. Yeah (0.3) so that just pull one pull pull down to them morning
12. Ph 05. Pull down to the one you want
13. Pt 09. And then the next dinner time
14. Ph 05. Yeah and make sure you only go so far with them=
15. Pt 09. =That’s right
16. Ph 05. Yeah
17. Pt 09. Otherwise you’ll mix your pills up
18. Ph 05. But if you wanted to have one in particular that you felt was easier for
19. Ph 05. you
20. Pt 09. No (0.2) I ain’t that far gone yet I mean I can=
Box 5 | Invoking the higher authority of the doctor: 1
1. Pt 03. My son sorts it all out for me
2. Ph 05. So does he will he fill that up every week
3. Pt 03. He will do=
4. Ph 05. =He will do okay so that’s your yeast tablets
they’re fine
5. Ph 05. they’re a course of treatment and how often do
you take
6. Ph 05. those
7. Pt 03. I don’t know
8. Ph 05. Do you just do you go by what’s on here
9. Pt 03. What’s put in the box yes
10. Ph 05. So you don’t (0.2) do you look at the labels at
all
11. Pt 03. No I don’t dear (0.2) he does
12. Ph 05. And how often do you take this for
13. Pt 03. I don’t know it is all (written) down there
14. Ph 05. How long will you be taking warfarin
15. Pt 03. I don’t know dear
16. Ph 05. ‘Til you’re told
17. Pt 03. Yes (0.2) I haven’t even phonedmy doctor yet
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assumed competence, integrity, and self governance.
These findings complement what is already known
about the difficult nature of advice giving in healthcare
communication generally,15 17 specifically for
pharmacists.3 11 23
Limitations and strengths of the study
The effect of the researcher as an observer is unknown.
It could have an effect on the consultation and may
inhibit either party. A further limitation of this study
is that we only included patients aged 80 or more and
it is possible that other patientsmay accept advice from
a pharmacist. This study, however, supports the find-
ings of the only other reported sociolinguistic study of
consultations between pharmacists and patients.11 This
was a hospital outpatient based study concerned with
young patients with cancer and their carers, where
pharmacists often give out advice and information uni-
laterally and patients and carers rarely ask any ques-
tions or initiate any topic changes.
The strength of this study is that observation and fol-
low-up interviews increase the credibility and trust-
worthiness of the findings: pharmacists confirm the
awkward nature of their advice giving task and patients
regularly confirm that they have learnt little from the
consultation. In addition, the same speech patterns
reported in the results were manifest in interactions
involving the sole male pharmacist.
This study raises several key issues for policy and
practice: it shows that interventions for medication
review need to develop further to ensure their rele-
vance and usefulness; it questions assumptions about
the appropriate advice giving role of the pharmacist; it
shows the pharmacy professions’ need and desire for
further training in communication skills; and it estab-
lishes that context and competence are important for
advice giving.23
Perhaps even more important are the policy conclu-
sions that can be drawn when the findings of this study
are considered in the light of the counterintuitive find-
ings from the parent trial: that medication review con-
sultations raise hospital admission rates, increase the
number of home visits by general practitioners, and
do not significantly increase quality of life. A possible
conclusion that supports other research concerned
with advice giving17 24 is that misaligned advice can
sow doubt in patients’ minds. This may lead to uncer-
tainty and ultimately to a loss of confidence in a
patient’s individual healthcare regimen. This study
suggests that caution should be exercised in assuming
that common sense interventions necessarily lead to
health gain.
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Box 6 | Invoking the higher authority of the doctor: 2 (italics indicate overlapping
speech)
1. Ph 04. Because I noticed your swollen ankles
2. Pt 22. Yes well my own doctor said he would try and come and see me
3. Pt 22. yesterday but he didn’t manage it but I should think he’ll be in today
4. Pt 22. sometime and then we’ll sort out these little problems when he comes
5. Ph 04. That’s good because you need to show him your ankles and tell him your
6. Ph 04. diuretic has been stopped
7. Pt 22. He immediately will know that (irritated)=
8. Ph 04. =Because I’mmean I’m I’m thinking that the diur because the diuretic
9. Ph 04. has been stopped perhaps your ankles are swelling up again
10. Pt 22. I think so yes that’s my private
11. Pt 22. opinion you see what’s good for one thing isn’t good for another
12. Ph 04. That’s absolutely right (0.2) now you’ve got a few more tablets in here
Box 7 | Unsettling effect on patients of pharmacists’ intervention
1. Ph 01. So (0.2) I think it is important that we do use the drops (0.2) regularly
2. Pt 06. Yeah
3. Ph 01. And (0.2) it is very important that I think I’ll I’ll have to let the doctor
4. Ph 01. know (0.2 ) so that (0.2) it might be necessary to have another pressure
5. Ph 01. test in between
6. Pt 06. Could I just say (0.2) that I feel that the way that my medicines have
7. Pt 06. been managed have been wonderful to keep me going so long in my
8. Pt 06. condition (0.2) that hh you know I’m so pleased really it’s worked out
9. Pt 06. well=
10. Ph 01. =Good
11. Pt 06. Yes marvellous I mean when you think how long I’ve gone on in fair
12. Pt 06. health for me (0.2) I think (0.2) you no I don’t feel like rocking the boat
13. Pt 06. if you know what I mean
14. Husband. No we don’t wish to complain
15. Pt 06. No we don’t wish to complain
16. Ph 01. No oh gosh no I’m not here to hh hh upset or rock the boat about
16. Ph 01. anything hhm
17. Pt 06. I think they’ve done wonderfully to work out what I need to keep
18. Pt 06. me going and she ((GP)) too has been very good (0.2) but I think it started
19. Pt 06. with doctor (name) who seemed to take a real interest in it they worked very
20. Pt 06. hard to get the right mixture for me (0.2) and it seems to be doing very well
WHAT IS ALREADY KNOWN ON THIS TOPIC
No research has been published on pharmacists’
communicative competence in their extended roles in the
United Kingdom;meanwhile medication review services are
being implemented nationwide
Pharmacists have not traditionally been trained in
healthcare communication
WHAT THIS STUDY ADDS
Reception and acknowledgement of advice in medication
reviewconsultationswithpharmacists is affectedbycontext
and communicative competence and may lead to negative
health gain
The extended role of the pharmacist is uncertain in older
patients’ (80 or more) management of their medicines
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